ISRCTN69696725已完成不适用
Randomised, controlled, double-blind trial of Chinese Herbal Medicine as adjuvant treatment in patients with Crohn's disease
Friedrich-Alexander-University of Erlangen-Nuremberg (Germany)0 个研究点目标入组 60 人开始时间: 2002年5月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. 60 participants
- •2. Disease duration greater than 1 year
- •3. Crohn's Disease Activity Index (CDAI) 150 - 450
- •4. Aged 18 - 60 years
排除标准
- •Not provided at time of registration.
研究者
相似试验
尚未招募
3 期
A randomized controlled, double-blind study of Chinese medicine combined with EGFR-TKI in the treatment of stage IV EGFR mutation-positive non-small cell lung cancerITMCTR1900002685Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine
招募中
不适用
Double-blind, randomized, controlled trial of the effects of probiotics for chemotherapy-induced gastrointestinal mucositisMultiple MyelomaJPRN-UMIN000010203Department of Hematology. Juntendo University School of medicine.40
已完成
2 期
A double-blind, randomized controlled trial of the effects of continuous intake of 1-kestose on defecation habits in children in kindergarteconstipationJPRN-UMIN000044252Center for Preventive Medical Sciences, Chiba University23
尚未招募
1 期
A double-blind randomized controlled trial of Qizhi Tongfeng Granule in the treatment of chronic refractory goutITMCTR2200006076Fangshan Hospital Affiliated to Beijing University of Chinese Medicine
已完成
不适用
A double-blind randomised controlled trial of the heat-inactivated Pediococcus acidilactici K15 in preterm infant to prevent viral respiratory tract infection after NICU discharge.Prevention of viral respiratory tract infectionJPRN-UMIN000033758Chiba University41